UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 551

Sortiert nach

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

Annals of internal medicine, 2020-02, Vol.172 (4), p.229

2020

Link zum Volltext

Verfügbarkeit prüfen

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Blood, 2013-08, Vol.122 (7), p.1316-1324

2013

Link zum Volltext

Verfügbarkeit prüfen

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

The New England journal of medicine, 2010-11, Vol.363 (22), p.2091-2101

2010

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

The Lancet. Haematology, 2016-03, Vol.3 (3), p.e119-e127

2016

Link zum Volltext

Verfügbarkeit prüfen

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

Blood, 2019-06, Vol.133 (26), p.2790-2799

2019

Link zum Volltext

Verfügbarkeit prüfen

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

Blood, 2013-09, Vol.122 (10), p.1813-1821

2013

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3249-3256

2014

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Blood, 2005-10, Vol.106 (8), p.2912-2919

2005

Link zum Volltext

Verfügbarkeit prüfen

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

Blood, 2022-03, Vol.139 (11), p.1694-1706

2022

Link zum Volltext

Verfügbarkeit prüfen

Conditioning regimens for hematopoietic cell transplantation: one size does not fit all

Blood, 2014-07, Vol.124 (3), p.344-353

2014

Link zum Volltext

Verfügbarkeit prüfen

Who is fit for allogeneic transplantation?

Blood, 2010-12, Vol.116 (23), p.4762-4770

2010

Link zum Volltext

Verfügbarkeit prüfen

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

PloS one, 2018-10, Vol.13 (10), p.e0205135-e0205135

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

JAMA : the journal of the American Medical Association, 2011-11, Vol.306 (17), p.1874

2011

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Cancer, 2008-05, Vol.112 (9), p.1992-2001

2008

Link zum Volltext

Verfügbarkeit prüfen

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

Blood, 2014-08, Vol.124 (8), p.1363-1371

2014

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4246-4254

2007

Link zum Volltext

Verfügbarkeit prüfen

Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation

Journal of clinical oncology, 2012-01, Vol.30 (1), p.71-77

2012

Link zum Volltext

Verfügbarkeit prüfen

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Blood, 2012-03, Vol.119 (11), p.2657-2664

2012

Link zum Volltext

Verfügbarkeit prüfen

Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4912-4920

2008

Link zum Volltext

Verfügbarkeit prüfen

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality

Blood, 2014-07, Vol.124 (2), p.287-295

2014

Link zum Volltext

Verfügbarkeit prüfen

Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system

Scientific reports, 2022-10, Vol.12 (1), p.17934-17934, Article 17934

2022

Link zum Volltext

Verfügbarkeit prüfen

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2859-2867

2010

Link zum Volltext

Verfügbarkeit prüfen

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease

Blood, 2013-03, Vol.121 (12), p.2340-2346

2013

Link zum Volltext

Verfügbarkeit prüfen

Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1993-2003

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 551

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(436)
Mit Volltextzugriff
(522)

Publikationsform

Sprache

Englisch
(551)
Japanisch
(78)

Erscheinungsjahr

n.n

Thema

Science & Technology
(287)
Life Sciences & Biomedicine
(285)
Humans
(245)
Hematology
(224)
Adult
(171)
Female
(170)
Middle Aged
(166)
Male
(165)
Transplantation
(149)
Aged
(137)
Immunology
(124)
Adolescent
(100)
Transplantation, Homologous
(99)
Biological And Medical Sciences
(97)
Medical Sciences
(93)
Transplantation Conditioning - Methods
(93)
Hematopoietic Stem Cell Transplantation
(86)
Hematopoietic Stem Cell Transplantation - Methods
(82)
Treatment Outcome
(78)
Oncology
(76)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(194)
Biology Of Blood And Marrow Transplantation
(112)
Bone Marrow Transplantation
(20)
Transplantation And Cellular Therapy
(18)
Haematologica
(17)
Journal Of Clinical Oncology
(16)
British Journal Of Haematology
(15)
Cancer
(12)
Leukemia
(12)
Transplantation
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

Conditioning regimens for hematopoietic cell transplantation: one size does not fit all

Who is fit for allogeneic transplantation?

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality

Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease

Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

Suchergebnisse filtern